Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

CUSIP: 45782T105

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
27,969,231
Total 13F shares
5,623,690
Share change
-539,613
Total reported value
$12,725,267
Put/Call ratio
211%
Price per share
$2.31
Number of holders
78
Value change
-$10,010,248
Number of buys
47
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 45782T105?
CUSIP 45782T105 identifies INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q2 2025

As of 30 Jun 2025, Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,623,690 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES FINANCIAL INC, STATE STREET CORP, Dauntless Investment Group, LLC, Rhenman & Partners Asset Management AB, NORTHERN TRUST CORP, and XTX Topco Ltd. This page lists 79 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.